1,159
Views
26
CrossRef citations to date
0
Altmetric
Review

Investigational drugs for treating major depressive disorder

Pages 9-24 | Received 27 Sep 2016, Accepted 29 Nov 2016, Published online: 14 Dec 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

George Konstantakopoulos, Stefanos Dimitrakopoulos & Panayiota G. Michalopoulou. (2020) The preclinical discovery and development of agomelatine for the treatment of depression. Expert Opinion on Drug Discovery 15:10, pages 1121-1132.
Read now
Martín Estrada-Valencia, Clara Herrera-Arozamena, Concepción Pérez, Dolores Viña, José A. Morales-García, Ana Pérez-Castillo, Eva Ramos, Alejandro Romero, Erik Laurini, Sabrina Pricl & María Isabel Rodríguez-Franco. (2019) New flavonoid – N,N-dibenzyl(N-methyl)amine hybrids: Multi-target-directed agents for Alzheimer´s disease endowed with neurogenic properties. Journal of Enzyme Inhibition and Medicinal Chemistry 34:1, pages 712-727.
Read now

Articles from other publishers (24)

Kihang Choi. (2023) The Structure-property Relationships of GPCR-targeted Drugs Approved between 2011 and 2021. Current Medicinal Chemistry 30:31, pages 3527-3549.
Crossref
Hongsong Feng, Jian Jiang & Guo-Wei Wei. (2023) Machine-learning repurposing of DrugBank compounds for opioid use disorder. Computers in Biology and Medicine 160, pages 106921.
Crossref
Camila Salvador Sestario, Viviane de Fátima Mestre, Caio Cezar Nantes Martins, Aline Campos Zeffa, Márjori Frítola & Maria José Sparça Salles. (2022) Congenital anomalies and spontaneous abortion in mice resulting from the use of escitalopram. Reproduction, Fertility and Development 34:17, pages 1099-1106.
Crossref
Grigorios N. Karakatsoulis & Konstantinos N. Fountoulakis. 2022. Glutamate and Neuropsychiatric Disorders. Glutamate and Neuropsychiatric Disorders 261 282 .
Clarissa Yates, Jennifer L. Kruse, J. Blair Price, Avril A. B. Robertson & Susannah J. Tye. (2021) Modulating Neuroplasticity: Lessons Learned from Antidepressants and Emerging Novel Therapeutics. Current Treatment Options in Psychiatry 8:4, pages 229-257.
Crossref
Shereen Mohamed Abdel Mawella, Hoda Abdou Hussein, Fadia Zyada, Amal Abdelaal, Doaa R. Ayoub & Ahmed Naguy. (2021) Psychoendocrinology: arginine vasopressin and resilience in patients with major depressive disorder. CNS Spectrums, pages 1-5.
Crossref
Serena Silvestro, Placido Bramanti & Emanuela Mazzon. (2021) Role of Quercetin in Depressive-Like Behaviors: Findings from Animal Models. Applied Sciences 11:15, pages 7116.
Crossref
Adejoke Yetunde Onaolapo & Olakunle James Onaolapo. (2021) Glutamate and depression: Reflecting a deepening knowledge of the gut and brain effects of a ubiquitous molecule. World Journal of Psychiatry 11:7, pages 297-315.
Crossref
Donald J. AbrahamRichard A. Glennon & Leslie Iversen. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 1 56 .
Ross J. Baldessarini, Gustavo H. Vázquez & Leonardo Tondo. (2020) Bipolar depression: a major unsolved challenge. International Journal of Bipolar Disorders 8:1.
Crossref
Yu Du, Xin-Ran Gao, Lei Peng & Jin-Fang Ge. (2020) Crosstalk between the microbiota-gut-brain axis and depression. Heliyon 6:6, pages e04097.
Crossref
Li Zi-Rong, Han Yuan-Shan, Wu Meng-Yao, Liu Jian, Jin Shi, Zhang Xi & Wang Yu-Hong. (2020) Compound Chai Jin Jie Yu Tablets, Acts as An Antidepressant by Promoting Synaptic Function in the Hippocampal Neurons. Digital Chinese Medicine 3:2, pages 80-95.
Crossref
Ke Fang, Hua-Rong Li, Xing-Xing Chen, Xin-Ran Gao, Ling-Ling Huang, An-Qi Du, Chuan Jiang, Hua Li & Jin-Fang Ge. (2020) Quercetin Alleviates LPS-Induced Depression-Like Behavior in Rats via Regulating BDNF-Related Imbalance of Copine 6 and TREM1/2 in the Hippocampus and PFC. Frontiers in Pharmacology 10.
Crossref
Ross J. Baldessarini, Leonardo Tondo & Gustavo H. Vázquez. 2020. New Directions in Psychiatry. New Directions in Psychiatry 39 82 .
Qiushi Yang, Xuelin Zhou, Jingyi Li, Yi Ma, Li Lu, Jie Xiong, Pingxiang Xu, Yuhang Li, Yi Chen, Wei Gu, Ming Xue, Zengliang Jin & Xiaorong Li. (2019) Sub-Acute Oral Toxicity of a Novel Derivative of Agomelatine in Rats in a Sex-Dependent Manner. Frontiers in Pharmacology 10.
Crossref
Elizabeth A.M. Frost. (2019) Ketamine. Topics in Pain Management 34:6, pages 1-7.
Crossref
Xiujuan Chen, Chen Liang, Lijun Cui, Jian Le, Zheyuan Qian, Runsheng Zhang, Zhanying Hong & Yifeng Chai. (2019) A rapid LC-MS/MS method for simultaneous determination of quetiapine and duloxetine in rat plasma and its application to pharmacokinetic interaction study. Journal of Food and Drug Analysis 27:1, pages 323-331.
Crossref
Hui-jiao Sun, Yu-hua Wang, Cong-min Yuan, Ling-hui Kong, Xue-jun Xu, Yu-jun Wang, Hai-hao Wu, Cheng Lin, Yuan-yuan Qian, Huo-ming Huang, Li Xiao, Xiao Liu, Qian He, Sheng-yang Fang, Deng-qi Xue, Xi-cheng Yang, Hao Chen, Yi-lin Zheng, Lan Zheng, Lin-qian Yu, Qiong Xie, Wei Fu, Wei Li, Jing-gen Liu, Zhui-bai Qiu & Li-ming Shao. (2018) 7β-Methyl substituent is a structural locus associated with activity cliff for nepenthone analogues. Bioorganic & Medicinal Chemistry 26:14, pages 4254-4263.
Crossref
F. Caraci, F. Calabrese, R. Molteni, L. Bartova, M. Dold, G. M. Leggio, C. Fabbri, J. Mendlewicz, G. Racagni, S. Kasper, M. A. Riva & F. Drago. (2018) International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets. Pharmacological Reviews 70:3, pages 475-504.
Crossref
L. Grassi, M.G. Nanni, G. Rodin, M. Li & R. Caruso. (2018) The use of antidepressants in oncology: a review and practical tips for oncologists. Annals of Oncology 29:1, pages 101-111.
Crossref
M. F. Lazenka & B. A. Hutsell. (2017) Preclinical Models for Assessment of Antidepressant Abuse Potential. Current Sexual Health Reports 9:4, pages 241-250.
Crossref
Jiyao Sheng, Shui Liu, Yicun Wang, Ranji Cui & Xuewen Zhang. (2017) The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain. Neural Plasticity 2017, pages 1-10.
Crossref
Gerd Laux. 2017. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie 1711 1817 .
Gerd Laux. 2016. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie 1 107 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.